Similar articles

• Both antigen optimization and lysosomal targeting are required for enhanced anti-tumour protective immunity in a human papillomavirus E7-expressing animal tumour model.

  Kim MS, Sin JI. Kim MS, et al. Immunology. 2005 Oct;116(2):255-66. doi: 10.1111/j.1365-2567.2005.02219.x. Immunology. 2005. PMID: 16162274 Free PMC article.
• Stimulation of non-specific anti-tumour resistance in the mouse using cell wall preparations from four BCG substrains.

  Beaudet R, Frenette M, Portelance V. Beaudet R, et al. Ann Immunol (Paris). 1983 Mar-Apr;134C(2):215-26. doi: 10.1016/s0769-2625(83)80093-2. Ann Immunol (Paris). 1983. PMID: 6223571
• Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8(+) T cells-mediated protection against melanoma B16 challenge.

  Mazorra Z, Mesa C, Fernández A, Fernández LE. Mazorra Z, et al. Cancer Immunol Immunother. 2008 Dec;57(12):1771-80. doi: 10.1007/s00262-008-0503-8. Epub 2008 Mar 20. Cancer Immunol Immunother. 2008. PMID: 18351335 Free PMC article.
• Memory T cells in cancer immunotherapy: which CD8 T-cell population provides the best protection against tumours?

  Perret R, Ronchese F. Perret R, et al. Tissue Antigens. 2008 Sep;72(3):187-94. doi: 10.1111/j.1399-0039.2008.01088.x. Epub 2008 Jul 9. Tissue Antigens. 2008. PMID: 18627571 Review.
• Mesenchymal Stem/Stromal Cells May Decrease Success of Cancer Treatment by Inducing Resistance to Chemotherapy in Cancer Cells.

  Ramuta TŽ, Kreft ME. Ramuta TŽ, et al. Cancers (Basel). 2022 Aug 2;14(15):3761. doi: 10.3390/cancers14153761. Cancers (Basel). 2022. PMID: 35954425 Free PMC article. Review.